Published January 2017 | Version v1
Journal article Metadata-only

Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer

Creators

  • 1. Genesis Cancer Care, Sydney (Australia)
  • 2. University of Sydney, Sydney (Australia)
  • 3. Department of Radiation Oncology, Royal North Shore Hospital (Australia)
  • 4. University of New South Wales, Sydney (Australia)
  • 5. Department of Nuclear Medicine, St Vincent's Hospital (Australia)
  • 6. Department of Nuclear Medicine and PET, Royal North Shore Hospital (Australia)

Description

Background and purpose: We investigated the role of 68Ga-PSMA-PET (PSMA) to determine the location of disease recurrence in those with a rising PSA following definitive external beam radiation treatment (EBRT).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2016.11.023

Additional details

Identifiers

DOI
10.1016/j.radonc.2016.11.023;
PII
S0167814016344206;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
122
Journal Issue
1
Journal Page Range
p. 99-102
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50080992
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
GALLIUM 68; NEOPLASMS; POSITRON COMPUTED TOMOGRAPHY; PROSTATE
Descriptors DEC
BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; GALLIUM ISOTOPES; GLANDS; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; ISOTOPES; MALE GENITALS; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOISOTOPES; TOMOGRAPHY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.